We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+9.27%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$49B
AUM Growth
+$3.11B
(+6.8%)
Cap. Flow
+$228M
Cap. Flow
% of AUM
0.47%
Top 10 Holdings %
Top 10 Hldgs %
21.37%
Holding
1,104
New
303
Increased
294
Reduced
324
Closed
153
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$282M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$205M |
| 3 |
ConocoPhillips
COP
|
+$203M |
| 4 |
Fortive
FTV
|
+$200M |
| 5 |
Merck
MRK
|
+$178M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$665M |
| 2 |
ExxonMobil
XOM
|
+$332M |
| 3 |
Burlington
BURL
|
+$242M |
| 4 |
National Vision
EYE
|
+$186M |
| 5 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$175M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.67% |
| 2 | Healthcare | 17.99% |
| 3 | Financials | 14.03% |
| 4 | Consumer Discretionary | 11.97% |
| 5 | Communication Services | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Mondelez International
MDLZ
$79B
| $91.9M | 0.19% |
1,569,497
-18,600
| -1% | -$1.05M |
|
127
Crown Castle
CCI
$31.6B
| $91.3M | 0.19% |
530,160
+144,600
| +38% | +$23.2M |
|
128
Bristol-Myers Squibb
BMY
$130B
| $90.9M | 0.19% |
1,439,139
-447,100
| -24% | -$27.8M |
|
129
Stryker
SYK
$130B
| $88.5M | 0.18% |
363,499
-700
| -0.2% | -$168K |
|
|
AEVA
130
Aeva Technologies
AEVA
$1.37B
| $88.5M | 0.18% |
+1,526,364
| New | +$119M |
|
131
Applied Materials
AMAT
$426B
| $87.4M | 0.18% |
654,026
+69,700
| +12% | +$7.69M |
|
132
Automatic Data Processing
ADP
$108B
| $87.3M | 0.18% |
463,076
+136,100
| +42% | +$23.6M |
|
|
KSU
133
DELISTED
Kansas City Southern
KSU
| $86.8M | 0.18% |
329,013
+225,013
| +216% | +$48.9M |
|
134
US Bancorp
USB
$100B
| $84.4M | 0.17% |
1,525,900
+10,200
| +0.7% | +$509K |
|
135
Array Technologies
ARRY
$894M
| $83.5M | 0.17% |
2,800,000
+2,358,590
| +534% | +$94.2M |
|
|
XLNX
136
DELISTED
Xilinx Inc
XLNX
| $83.2M | 0.17% |
671,350
-1,000
| -0.1% | -$133K |
|
137
Zoetis
ZTS
$31.5B
| $83M | 0.17% |
527,354
+69,965
| +15% | +$11.1M |
|
138
M&T Bank
MTB
$36.8B
| $82.8M | 0.17% |
546,132
-132,758
| -20% | -$19.6M |
|
139
General Dynamics
GD
$104B
| $82.4M | 0.17% |
453,916
+12,920
| +3% | +$2.11M |
|
140
Bunge Global
BG
$21B
| $81.3M | 0.17% |
1,025,242
-492,000
| -32% | -$36.6M |
|
141
General Motors
GM
$78.1B
| $81.2M | 0.17% |
1,412,786
-127,302
| -8% | -$6.76M |
|
142
Vulcan Materials
VMC
$37.4B
| $80.9M | 0.17% |
479,423
+334,640
| +231% | +$54.3M |
|
143
Aclaris Therapeutics
ACRS
$851M
| $80.6M | 0.16% |
3,200,000
+950,000
| +42% | +$18.6M |
|
144
Sherwin-Williams
SHW
$89B
| $80.4M | 0.16% |
327,006
-128,349
| -28% | -$30.6M |
|
145
CME Group
CME
$93.7B
| $80.1M | 0.16% |
392,231
+3,600
| +0.9% | +$709K |
|
146
Autodesk
ADSK
$50.5B
| $80M | 0.16% |
288,589
+45,500
| +19% | +$13.1M |
|
|
FLIR
147
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $78.7M | 0.16% |
1,392,935
+1,177,381
| +546% | +$64M |
|
148
CSX Corp
CSX
$94.2B
| $78M | 0.16% |
2,428,404
+253,800
| +12% | +$7.75M |
|
149
Lightspeed Commerce
LSPD
$1.34B
| $78M | 0.16% |
1,242,080
+155,632
| +14% | +$10.6M |
|
150
Baxter International
BAX
$14.3B
| $77.8M | 0.16% |
922,902
+353,900
| +62% | +$28.1M |
|
Similar funds
Adage Capital Partners's Q1 2021 Portfolio in Review
As of Q1 2021, Adage Capital Partners held 1,104 positions worth $49B, up 6.8% from $45.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Adage Capital Partners's Q1 2021 filing shows 303 new, 294 increased, 324 reduced and 153 closed positions. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 1,500,000 shares worth $325M. The largest sale was Royalty Pharma, an estimated $665M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
- Adage Capital Partners's largest Q1 2021 buy was GW Pharmaceuticals Plc American Depositary Shares: 1,500,000 shares worth $325M.
- Adage Capital Partners added most to Alexion Pharmaceuticals in Q1 2021, an estimated $205M increase.
- Adage Capital Partners's biggest Q1 2021 reduction was Royalty Pharma, cutting an estimated $665M.
- Adage Capital Partners fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $175M.
- Adage Capital Partners's ten largest holdings make up 21% of its $49B portfolio in Q1 2021.
- Adage Capital Partners opened 303 new positions and closed 153 in Q1 2021.
- Adage Capital Partners's portfolio value rose 6.8% quarter-over-quarter to $49B.
Based on Adage Capital Partners's 13F filing for Q1 2021, filed 17 May 2021.